DOCSLIB.ORG

2018 Star Reviewers for Urologic Oncology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2018 Star Reviewers for Urologic Oncology Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 2018 Star Reviewers for Urologic Oncology While the value of any medical journal depends upon the Sabine Brookman-May, Ph.D., M.D. quality of manuscripts received, the backbone of a journal’s LMU Munich, Dept. of Urology, Munich, Germany success is created by those who review manuscripts, iden- Clint Cary, M.D., M.P.H. tify problematic issues, make critical suggestions for Urology, Indiana University School of Medicine, Indianapolis, improvement, and assist the journal’s editors in deciding on Indiana, United States a manuscript’s disposition. This is no small task, and all too Edmund Chiong, M.B.B.S., Ph.D., F.R.C.S.Ed, F.R.C.S.I, F.A.M.S often it may feel thankless. Urology, National University Health System, Singapore, Singapore By acknowledging those reviewers whom our editors Nicholas Cost, M.D. have identified as “Star Reviewers,” Urologic Oncology Department of Surgery, Division of Urology, University of seeks to underscore the outstanding work that these Colorado School of Medicine, Aurora, CO, United States reviewers have done for the Journal over the course of this Chendil Damodaran, Ph.D. past year. We also wish to identify and thank all reviewers Urology, Univiersity of Louisville, Louisville, KY, United States for their excellent work and contributions in 2018. The Alexander Glaser, M.D. April 2019 issue of Urologic Oncology will therefore con- Department of Urology, Northwestern University, Chicago, IL, tinue its tradition of recognizing its reviewers such that all United States of our 2018 Reviewers and the Editors’ “Star Reviewers” Michael Gorin, M.D. will be formally acknowledged in the Journal with deep The James Buchanan Brady Urological Institute and Depart- ment of Urology, Johns Hopkins University School of Medicine gratitude. Maximilien Goris Gbenou, M.D. By providing your expertise, perspectives, knowledge, Urology, Centre Hospitalier de Valence, Valence, 26000, and insight, you − our reviewers − help immeasurably to Belgium enhance the value of Urologic Oncology to the readership Gabriel Haas, MD, F.A.C.S. as well as to those who contribute their work to the Journal. Medical Affairs-global, Astellas Pharma lobal Development, Inc., Northbrook, IL, United States In this, simple words cannot adequately express the grati- Marie Hupe, M.D. tude that I and my co-Editors deeply feel. Department of Urology, University Hospital Schleswig- So, simply said, a big THANK YOU from us all. Holstein Campus Luebeck, Lubeck,€ Germany The Editors and Publisher of Urologic Oncology: Zachary Klaassen, M.D. Seminars and Original Investigations, Division of Urology, Medical College of Georgia - Augusta University, Augusta, Georgia, United States Star Reviewers, 2018 Sarrah Lahorewala, United States Parth Modi, M.D., M.S. Takashige Abe, M.D./Ph.D. Urology, University of Michigan, Ann Arbor, Michigan, Department of Urology, Hokkaido University Graduate United States School of Medicine, Sapporo, Hokkaido, Japan William Parker, M.D. Safiye Aktas, M.D., Ph.D. Urology, University of Kansas Medical Center, Kansas City, Basic Oncology, Institute of Oncology, Izmir, Turkey KS, United States Aditya Bagrodia, M.D. Jose A Pedrosa, M.D. Urology, UT Southwestern, Dallas, TX, United States Urology, Department of Urology, Indiana University, Mark Ball, M.D. Indianapolis, IN, United States Urologic Oncology Branch, National Cancer Institute, Debasish Sundi, M.D. National Institutes of Health, Bethesda, MD, United States Urology, The Ohio State University, Columbus, Luca Boeri, M.D. OH Department of Urology, Fondazione IRCCS Ca’ Granda - Gang Wang, M.D, Ph.D Ospedale Maggiore Policlinico, University of Milan, Milan, Pathology, BC Cancer Vancouver Centre, Vancouver, British Italy Columbia, Canada https://doi.org/10.1016/j.urolonc.2019.02.016 230 / Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 Stephen Williams, M.D. Stefanos Adamis, M.D., Ph.D. Urology, The University of Texas Medical Branch, Galveston, Athens, Greece TX, United States Mehrad Adibi, Urology, MD Anderson Cancer Center, Nassau Bay, All Reviewers, 2018 United States Julieta Afonso, Cory Abate-Shen Life and Health Sciences Research Institute, Columbia University, Department of Urology, University of Minho, Braga, Portugal New York, United States Neeraj Agarwal, M.D. Ronney Abaza, M.D., F.A.C.S. Internal Medicine/Medical Oncology, Huntsman Ohio State University Medical Center & Cancer Institute at the University of Utah, Salt Lake James Cancer Hospital, Columbus, OH, City, UT, United States United States Piyush Agarwal, M.D. Phillip Abbosh, M.D., Ph.D. National Cancer Institute, National Institutes of Surgical Oncology, Division of Urologic oncology, Fox Health, Bethesda, MD, United States Chase Cancer Center, Philadelphia, PA, United States Vivek Agarwala, M.D., D.M. Rania Abd-Ellatif, Ph.D. Medical Oncology, Tata Memorial Centre, Mumbai, Medical Biochemistry, Faculty of Medicine, Tanta, India Egypt Rahul Aggarwal, M.D. Aziza Abdelrahman, Ph.D., M.D. Hematology/Oncology, University of California San pathology, Faculty of medicine, Zagazig University, Francisco, San Francisco, CA, United States Zagazig, Egypt Nnenaya Agochukwu, M.D. Hamidreza Abdi, M.D. Urology, Yale New Haven Hospital/Yale School Of Urology, University of Ottawa, Ottawa, ON, Canada Medicine, Ann Arbor, MI, United States Firas Abdollah Faik, M.D. Vinita Agrawal, M.D. Vattikuti Urology Institute, Henry Ford Health Pathology, SGPGIMS, Lucknow, Uttar Pradesh, India System, Detroit, MI, United States Nariman Ahmadi, M.B.B.S., M.S., F.R.A.C.S. E Jason Abel, M.D. Urology, Chris O’brien Lifehouse, Camperdown, Houston, United States NSW, Australia E. Jason Abel, M.D. Hashim Ahmed, Ph.D., F.R.C.S. (Urol), B.M., B.Ch. Department of Urology, University of Wisconsin (Oxon), B.A. (Hons) School of Medicine and Public Health, Madison, WI, Imperial College London, Division of Surgery, Lon- United States don, United Kingdom Michael Abern, M.D. Khalil Ahmed, Department of Urology, University of Illinois at Lab Med Path, University of Minnesota and Chicago, Chicago, IL, United States MVAHCS, Minneapolis, MN, United Kingdom Aiysha Abid, Ph.D. Hanjong Ahn, M.D., Ph.D. Centre for Human Genetics and Molecular Medicine, Department of Urology, Department of Urology, Sindh Institute of Urology and Transplantation, Asan Medical Center, University of Ulsan College of Karachi, Pakistan Medicine, Seoul, Republic of Korea, Seoul, Korea, Hassan Abol-Enein, M.D., Ph.D. Republic of Urology, Urology and Nephrology Center, Mansoura, Sadia Ajaz, Ph.D. Dakahlia, Egypt University of Karachi, Karachi, Pakistan Robert Abouassaly, M.D. Hideyuki Akaza, M.D. Urologic Institute, University Hospitals Cleveland Japan Medical Center, Cleveland, United States Bulent Akdogan, M.D. Mohammad Abufaraj, M.D. Urology, Hacettepe University School of Medicine, Urology, Medical University of Vienna, Vienna, Ankara, Turkey vienna, Austria Haluk Akin, Prof.Dr. M.D. Naveen Acharya, Medical Genetics, Ege University Medical Faculty, Urology, Pgimer, Chandigarh, Chandigarh, India Izmir, Turkey Liana Adam, M.D., Ph.D. Yigit Akin, M.D. Urology, UT MD Anderson CC, Houston, Texas, Department of Urology, Izmir Katip Celebi Univer- United States sity School of Medicine, Izmir, Turkey Przemyslaw Adamczyk, M.D., Ph.D. Ashraf Al Matar, Department of general anf oncologic urology, Urology, King Fahad Specialist Hospital, Hofuf, Nicolaus Copernicus Hospital, Torun, Poland Saudi Arabia, Saudi Arabia / Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 231 Hikmat Al-Ahmadie, M.D. Magdy Aly, Ph.D. Pathology, Memorial Sloan Kettering Cancer Center, Zoology, Faculty of Science, Beni-Suef University, New York, NY, United States Beni-Suef, Egypt Ridwan Alam, M.D., M.P.H. Ruihua An, Ph.D., M.D. The James Buchanan Brady Urological Institute, The First Affiliated Hospital of Harbin Medical Department of Urology, Johns Hopkins University University, Harbin, China School of Medicine, Baltimore, Maryland, United Umberto Anceschi, M.D., F.E.B.U. States Urology, Regina Elena National Cancer Institute, Shaheen Alanee, M.D., M.P.H., M.B.A. Rome, Italy Urology, Vattikuti Urology Institute, Detroit, Michi- Sigve Andersen, Ph.D., M.D. gan, United States Department of oncology, University Hospital Ahmad Alaqqad, M.D. of North Norway HF, Tromsø, Norway Cleveland clinic Abu Dhabi, Abu dhabi, United Arab Christopher Anderson, M.D. Emirates Urology, Columbia University Medical Center, Osamah Al-Bayati, New York, New York, United States San Antonio, Texas, United States Priscila Andrade, Peter Albers, M.D. Sao Paulo, SP, Brazil Department of Urology, Du¨sseldorf University, Du¨s- Alessandro Antonelli, md seldorf, Germany Department of Urology. ASST Spedali Civili Michele Albert, M.D. Hospital. University of Brescia. Brescia, Italy, Radiation Oncology, Bridgham and Women’s Hospi- Brescia, Italy tal, Boston, MA, United States Alberto Antunes, Peter Albertsen, M.D., M.S. Laboratory of Medical Investigation - LIM 55 - Division of Urology, MC 3955, Unversity Division of Urology, University of Sao Paulo of Connecticut Health Center, Farmington, Medical School, Sa˜o Paulo, Brazil CT, United States Ana Aparicio, M.D. Mehrdad Alemozaffar, M.D. Department of Genitourinary Medical Oncology, MD atlanta, ca, United States Anderson Cancer Center, Houston, Texas, United Fernand Algaba, M.D. States Spain Andrea Apolo, M.D. Ahmed Ragab Ali, M.D. Medical Oncology Branch, National Cancer Institute, urology,
Load more

Recommended publications
  • Prospectus Symp19-8-2019.Indd
    EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS TH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM NOVEMBER 7-9, 2019 NEW YORK, NY MOUNTSINAIUROLOGYCME.ORG HIGHLIGHTS • Over 100 world-renowned faculty • Engaging point-counterpoint debates and • Live 3-D surgical demonstrations, including panel discussion prostate, kidney, bladder procedures • Global exposure with international web streaming of select sessions and events Welcome to the Fourth International Prostate Cancer and Urologic Oncology Symposium. EDUCATIONAL HIGHLIGHTS • Live 3-D surgery transmission covering complex urologic surgery • Comprehensive didactic lectures from the world’s leading experts in urologic oncology • Robust review of the latest advances in surgical techniques and management of prostate, kidney, and bladder cancer • Personal interaction with world-class faculty • Stimulating point-counterpoint debates on timely topics DAILY HIGHLIGHTS PROSTATE DAY 1 THUR. 11/7/19 PROSTATE DAY 2 FRI. 11/8/19 KIDNEY & BLADDER SAT. 11/9/19 • Advanced imaging in genomics • Innovations in the management of • New progress in pre-operative and for prostate cancer castrate-sensitive prostate cancer intra-operative imaging, 3-D • Biomarkers and immunotherapy modelling, and ultra sound • Focus on radiomics and guidance for renal tumors radiogenomics • Update on clinical trials for castrate-resistant treatments for • Novel therapeutics in the • Utility of imaging and artificial prostate cancer management of metastatic renal intelligence in prostate cancer cell carcinomas:
    [Show full text]
  • In the News September 30, 2016
    From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - September 30, 2016 Date: Friday, September 30, 2016 2:06:09 PM Attachments: ATT00002.txt In the News September 30, 2016 Nature – September 30 Inflammation in Patients With Cushing Disease — Claire Greenhill Circulating levels of proinflammatory cytokines are increased in patients with Cushing disease, both during active disease and after remission, according to new data published in Clinical Endocrinology. These findings demonstrate that cytokine levels are increased in patients after remission of Cushing disease, which could explain the persistent increased risk of cardiovascular-related death. The study, led by Eliza Geer, MD, a professor of endocrinology at the Icahn School of Medicine at Mount Sinai, notes that more studies are needed to determine why levels of IL-6 and IL-1β remain elevated after remission of Cushing disease. - Eliza Geer, MD, Associate Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Neurosurgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.nature.com/nrendo/journal/vaop/ncurrent/full/nrendo.2016.170.html WCBS – September 29 ‘Artificial Pancreas’ Expected To Make Life Easier, Healthier For Type 1 Diabetes Patients — Max Gomez A groundbreaking new device could change the lives of millions of people living with diabetes. Federal regulators just approved an artificial pancreas that can monitor and administer insulin. The key is a computer algorithm that does those calculations faster and more accurately than a patient can. “It looks at the numbers from a moment to moment basis, and it will proactively predict what is going to happen next and make clinical decisions that cannot be done at that rate.
    [Show full text]
  • Shares to Be Transferred To
    FOLIO CLBAL_2011 DIV_2011 CLBAL_2012 DIV_2012 CLBAL_2013 DIV_2013 CLBAL_2014 DIV_2014 CLBAL_2015 DIV_2015 CLBAL_2016 DIV_2016 CLBAL_2017 DIV_2017 BAL_220918 NAME FH_NAME ADDRESS1 ADDRESS2 ADDRESS3 ADD4 PIN JHNAME1 JHNAME2 C0380 350 525.00 350 525.00 350 700.00 350 700.00 350 700.00 350 700.00 350 700.00 350 PREM NATH CHAKRAVARTY 53 NEW BAIRANA ALLAHABAD. U.P. S0015 50 75.00 50 75.00 50 100.00 50 100.00 50 100.00 50 100.00 50 100.00 50 PARESH NATH SEN F/N P.B. SEN TOLAPHATAK SANTOSH KUNJ. CHINSURAH, HOOGHLY LAKSHMI NARAYAN C0112 2 3.00 2 3.00 2 4.00 2 4.00 2 4.00 2 4.00 2 4.00 2 CHOWDHURY F/N LATE S.S CHOWDHURY VILL & P.O BHATAKUL DIST. BURDWAN APURBANDHAN MUKHERJEE M0157 2 3.00 2 3.00 2 4.00 2 4.00 2 4.00 2 4.00 2 4.00 2 (DECD.) F/N LATE A.D.MUKHERJEE P.O. & VILL PAR-GOPALNAGAR DIST. HOOGHLY NIBARAN CHANDRA GHOSE G0019 150 225.00 150 225.00 150 300.00 150 300.00 150 300.00 150 300.00 150 300.00 150 (DECD.) F/N LATE B.N. GHOSE PALPARAH-CHANDERNAGORE DIST. HOOGHLY ABUBAKAR ISMAIL V0009 100 150.00 100 150.00 100 200.00 100 200.00 100 200.00 100 200.00 100 200.00 100 MARIAMBIBI DAVJEE VORAJEE F/N D.A.VORAJEE MOTAVARACHHA DT SURAT VORAJEE S0130 100 150.00 100 150.00 100 200.00 100 200.00 100 200.00 100 200.00 100 200.00 100 KAMALA BALA SEN H/N B.B.SEN CHOUMATHA, CHINSURAH DT.
    [Show full text]
  • In the News July 29, 2016
    From: ITNDaily on behalf of Stephanie Sherman Subject: Mount Sinai In The News - July 29, 2016 Date: Friday, July 29, 2016 11:20:39 AM Attachments: ATT00002.txt In the News July 29, 2016 WBUR News – July 28 Doctors Need A New Skill Set For This Opioid Abuse Treatment — Karen Shakerdge Braeburn Pharmaceuticals, the company behind the newly FDA-approved treatment Probuphine, is teaching doctors how to use it. Although addiction specialists welcome Probuphine, which delivers a constant dose of the drug buprenorphine over six months, at this early stage it's complicated for physicians to add it to their repertoire. Patients using Probuphine were 14 percent more likely to stay opioid-free compared to those using a daily sublingual version of buprenophine, according to a study published this month in JAMA, the Journal of the American Medical Association. So it's good to have another way to deliver medication-assisted treatment, says Richard Rosenthal, medical director of addiction psychiatry for the Mount Sinai Health System. Rosenthal was one of two principal investigators on a Probuphine clinical trial. "Everybody is waking up to the fact that we're in the midst of an opioid epidemic," says Rosenthal. "There are actually very few medications for addiction of any kind. Given the addiction treatment system in the United States, most of the treatment that's given is psychosocial. There's very little use of FDA-approved medications." - Richard N. Rosenthal. MD, Professor, Psychiatry, Mount Sinai West Learn more: http://www.wbur.org/npr/487080738/doctors-need-a-new-skill-set-for-this-opioid-abuse- treatment MD Alert – July 28 Some Non-Celiac Gluten Sensitivity Patients May Have 'Celiac Lite' Disease — Marilynn Larkin A subset of patients with non-celiac gluten sensitivity (NCGS) may actually have a form of celiac disease, researchers in Spain report.
    [Show full text]
  • PARTNERSHIP PROSPECTUS SEPTEMBER MOUNT SINAI HOSPITAL 7-9 NEW YORK, NEW YORK 2017 Second International Urologic Cancer Symposium
    EXHIBITOR AND PROMOTIONAL PARTNERSHIP PROSPECTUS SEPTEMBER MOUNT SINAI HOSPITAL 7-9 NEW YORK, NEW YORK 2017 Second International Urologic Cancer Symposium HIGHLIGHTS • Over 80 renowned global faculty • Live 3D surgical demonstrations, including prostate, kidney, bladder and reconstruction • Point-Counterpoint Debate • Annual Push Up Challenge • Gala to Raise Funds for Urologic Cancer Research TOPIC AREAS • Screening and Low Risk Disease • Localized Prostate Cancer • Biomarkers and Genomics • Advanced Prostate Cancer • Immunotherapy • Kidney Cancer • Focal Therapy • Bladder Cancer www.mountsinaiurologycme.org TABLE OFCONTENTS Invitation to Exhibit/Sponsor . 1 Department of Urology 75th Anniversary Session . 2 Screening & Low Risk Disease . 3 Focal Therapy . 4 Treatment Failure . 4 Immunotherapy & Tumor Microenvironment . 5 Radical Prostatectomy . 6 Treating Localized Disease . 7 Advanced Prostate Cancer . 8 Locally Advance Disease. 9 Quality of Life . 9 Kidney Cancer - I. 10 Kidney Cancer - II . 11 Kidney Cancer - III . 12 Bladder Cancer I . 13 Partnership Information . 14 Partnership Opportunities . 15 Exhibit Registration Form . 17 Agenda. 18 Invitation to Exhibit/Sponsor 1 Course Director Dear Industry Colleagues: Ash Tewari, MBBS, MCh On behalf of the Department of Urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City, I Co –Directors would like to invite you to partner with the 2nd International Urologic Cancer Symposium being held on September On behalf of the Department of Urology at the Icahn School of Medicine at Mount Sinai Hospital in New Ketan K. Badani, MD 6-9, 2017 at the Mount Sinai School of Medicine in New York, NY. Ranked among the nation’s best for Urology York City, I would like to invite you to partner with the Second International Prostate Cancer Nina Bhardwaj, MD, PhD in the 2016-2017 "Best Hospitals" issue of U.S.
    [Show full text]
  • Curriculum Vitae [PDF]
    CURRICULUM VITAE GYAN PAREEK, M.D. Academic Address: 2 Dudley Street, Suite 174 Providence, RI 02905 Academic Telephone Number: 401-444-8570 Academic Fax Number: 401-444-6947 Mobile Number: 401-537-7763 Electronic Mail Address: [email protected] EDUCATION Undergraduate: University of Pittsburgh, Pittsburgh, PA Bachelor of Science in Neuroscience, 1991 Graduate: Roswell Park Cancer Institute, SUNY at Buffalo Buffalo, NY Master of Science, 1993 Brown University Providence, RI Master of Arts ad eundem, 2014 Harvard Medical School Boston, MA 2018-Current Harvard Certificate in Leadership Medical School: St. George’s University School of Medicine, M.D., 1998 POSTGRADUATE TRAINING Residency: Lenox Hill Hospital, New York, NY Surgery (PGY1), 7/1/1998-6/30/1999 Lenox Hill Hospital, New York, NY Surgery (PGY2), 7/1/1999-6/2000 Lenox Hill Hospital, New York, NY Urology, 7/1/2000-6/30/2004 Fellowship: Laparoscopy and Endourology, University of Wisconsin, Madison, WI Clinical Instructor, 7/1/2004-6/30/2005 1 POSTGRADUATE HONORS AND AWARDS 2004 American Urological Association Pfizer Scholar 2005 Annual Essay Contest, Second Place, “Basic Science” and “Elastographic Measurements of In-Vivo Radiofrequency Ablation Lesions of the Kidney.” Endourological Society, Amsterdam, Netherlands 2006 Urology (Gold Journal) Essay Contest, Second Place, “Shockwave Lithotripsy Success Based on Skin to Stone Distance on Computed Tomography.” American Urological Association, Atlanta, Georgia 2009 The Dean’s Excellence in Teaching Award, “Urology Clinical Elective”,
    [Show full text]
  • Village Doctors and Vulnerable Bodies: Gender, Medicine, and Risk in North India
    Syracuse University SURFACE Dissertations - ALL SURFACE December 2018 Village Doctors and Vulnerable Bodies: Gender, Medicine, and Risk in North India Jocelyn Killmer Syracuse University Follow this and additional works at: https://surface.syr.edu/etd Part of the Social and Behavioral Sciences Commons Recommended Citation Killmer, Jocelyn, "Village Doctors and Vulnerable Bodies: Gender, Medicine, and Risk in North India" (2018). Dissertations - ALL. 962. https://surface.syr.edu/etd/962 This Dissertation is brought to you for free and open access by the SURFACE at SURFACE. It has been accepted for inclusion in Dissertations - ALL by an authorized administrator of SURFACE. For more information, please contact [email protected]. ABSTRACT This dissertation tracks an uncommon migration: the movement of young women doctors from urban medical colleges to rural clinics in Rajasthan, North India. The ability for young women doctors to transfer their lives to a rural clinic, even for a year or two, is vital for career advancement in Rajasthan’s government health sector. Yet I found that women, over and over, rejected this opportunity, turning this urban to rural migration into a trickle rather than a flow. Through interviews, observations, and travel in urban and rural Jaipur district, I explore the meanings of urban and rural spaces as well as contested understandings of what role doctors should play in the health of the population. I found that rural spaces were discursively marked as particularly dangerous for doctors who are urban, middle-class women. First, moving to a “village of strangers” required shedding one’s protective social network and the paternalistic surveillance that accompanies it.
    [Show full text]
  • Annexure-I Selected Awardees Under the Scheme of P.G
    1 of 101 Pages 6th February, 2014 Annexure-I Selected awardees under the scheme of P.G. Scholarship for Single Girl Child for the academic programme 2013-2015 S.No Candidate ID Name Father Name Mother Name DOB PG Degree Subject Coll/Uni Name final Remarks OSMANIA UNIVERSITY 1 SGC-OBC-2013-13833 KONDA LAXMI KONDA SAILU KONDA SAYAVVA 05/07/1992 M.A POLITICAL SCIENCE Awarded 2 SGC-SC-2013-15220 ANUSREE SAHA MANIKESWAR SAHA BAISALI SAHA 10/10/1991 M.SC ZOOLOGY THE UNIVERSITY OF BURDWAN Awarded 3 SGC-GEN-2013-17416 LAKSHMI S KUMAR S SUDHEER KUMAR K R SUDHA KUMARY 05/02/1993 MA MALAYALAM FATHIMA MATHA NATIONAL COLLEGE Awarded HAM-AK RURAL COLLEGE OF MANAGEMENT & 4 SGC-GEN-2013-17858 MISSPAB JALIL ULLAH SAMSUN NAHER 30/08/1987 M.A EDUCATION TECHNOLOGY Awarded 5 SGC-GEN-2013-18801 SCINDIA A RAMASAMY R EMALDA 05/03/1991 M.SC physics SHRIMATHI INDHRA GANDHI COLLEGE TRICHY Awarded 6 SGC-GEN-2013-13773 SYAMA S PILLAI MURALEEDHARAN PILLAI B SAKUNTHALAMURALI 14/04/1993 MSC PHYSICS CATHOLICATE COLLEGE-PATHANAMTHITTA Awarded 7 SGC-GEN-2013-12968 A ARAVINTHALAKSHMI N ANNAMALAI A MEENAL ANNAMALAI 13/09/1992 M.A DEVELOPMENT MANAGEMENT MADRAS SCHOOL OF SOCIAL WORK Awarded 8 SGC-OBC-2013-14722 A J ROSHI ROHINI A AZHAKESA PERUMAL PILLAI A JEYALEKSHMI 06/01/1991 MA ENGLISH LITERATURE HOLY CROSS COLLEGE Awarded DHANALAKSHMI SRINIVASAN COLLEGE OF ARTS & 9 SGC-GEN-2013-17494 A JENIFER BABY ANTONY MARIYANATHAN JOSHPINE SAGAYARANI 05/01/1992 M.A ENGLISH SCIENCE FOR WOMEN Awarded 10 SGC-SC-2013-19257 A KALAI SELVI R ANANDHAN A JOTHI MANI 03/12/1992 M.COM commerce and computer applications Bharathiar university Awarded 11 SGC-GEN-2013-12849 A.
    [Show full text]
  • Bengali Sentimental Booklet
    BENGALI SENTIMENTAL - 200 SONGS 10. Balukabelay Kurai Jhinuk Album: All Time Greats - 01. Duti Pakhi Duti Teere Satinath Mukherjee Album: Songs To Remember Artiste: Satinath Mukherjee Artiste: Talat Mahmood Lyricist: Gauriprasanna Mazumder Lyricist: Girin Chakraborty Music Director: Satinath Mukherjee Music Director: Kamal Dasgupta 11. Emon Din Aaste Pare 02. Adho Raate Jodi Ghum Bhenge Album: Chayanika Album: Sera Shilpi Sera Gaan Volume 6 Artiste: Shyamal Mitra Artiste: Talat Mahmood Lyricist: Gauriprasanna Mazumder Lyricist: Anil Bhattacharya Music Director: Shyamal Mitra Music Director: Nirmal Bhattacharya 12. Hoyto Kichhui Nahi Pabo 03. Hay Hay Go Raat Jay Go Album: Solid Gold – Shyamal Mitra Album: Chayanika Artiste: Sandhya Mukherjee Artiste: Manna Dey Lyricist: Gauriprasanna Mazumder Lyricist: Gauriprasanna Mazumder Music Director: Shyamal Mitra Music Director: Manna Dey 13. Srimati Je Kande 04. Chithi (Tumi Aaj Kato Durey) Album: Chayanika Gems From Bengal Album: Jaganmoy Mitra - Volume 2 Tumi Ki Ekhono Artiste: Malay Mukherjee Artiste: Jaganmoy Mitra Lyricist: Miltoo Ghosh Lyricist: Pronab Roy Music Director: Sailen Mukherjee Music Director: Subal Dasgupta 14. Kato Nishi Gechhe Nidhara 05. Aar Kato Rohibo Sudhu Path Album: Sera Shilpi Sera Gaan, Vol 4 Album: Katha Koyo Naako Shudhu Sono Artiste: Lata Mangeshkar Artiste: Hemanta Mukherjee Lyricist: Pabitra Mitra Lyricist: Gauriprasanna Mazumder Music Director: Satinath Mukherjee Music Director: Satinath Mukherjee 15. Aakash Pradip Jwale 06. Ogo Mor Geetimoy Album: Sera Shilpi Sera Gaan, Vol 4 Album: Chayanika Artiste: Lata Mangeshkar Artiste: Sandhya Mukherjee Lyricist: Pabitra Mitra Lyricist: Kamal Ghosh Music Director: Satinath Mukherjee Music Director: Robin Chatterjee 16. Tumi Aar Deko Na 07. Ami Chole Gele Pashaner Buke Album: Hits Of Manna Dey Volume 2 Album: All Time Greats - Artiste: Manna Dey Satinath Mukherjee Lyricist: Gauriprasanna Mazumder Artiste: Satinath Mukherjee Music Director: Manna Dey Lyricist: Shyamal Gupta 17.
    [Show full text]
  • In the News June 1, 2018
    From: ITNDaily Subject: Mount Sinai In The News - June 1, 2018 Date: Friday, June 01, 2018 1:51:23 PM Attachments: ATT00001.txt In the News June 1, 2018 Core77 – May 31 A Clinic And Research Lab Designed To Make The Patient Experience Pleasant and Comprehensive — Emily Engle Medical spaces need a facelift, from furnishing to digital screens to the entire patient experience. This past year, Cactus team worked closely with the Mount Sinai Health System to develop Lab100, a new type of medical environment that focuses on the different ways in which developing technologies can improve how we understand and experience medical attention and healthcare. Lab100 equips scientists with longitudinal multi-scale health data and a testbed environment to develop, validate and deploy new products and services. By closing the feedback loop between discovery science and care delivery, Lab100 creates a virtuous cycle of innovation that radically accelerates the pace at which promising ideas become clinical practice. - David Stark, MD, Assistant Professor, Health System Design and Global Health, Icahn School of Medicine at Mount Sinai, Medical Director, Institute for Next Generation Health Care Learn more: http://www.core77.com/posts/77952/A-Clinic-and-Research-Lab-Designed-to-Make-the-Patient-Experience-Pleasant-and-Comprehensible International Business Times – June 1 Mount Sinai And RenalytixAI Launch Groundbreaking Artificial Intelligence Solution For Improved Kidney Disease Management and Patient Care Mount Sinai Health System and RenalytixAI, Plc today have entered into an exclusive multi-year license and collaboration to commercialize artificial intelligence solutions to improve kidney disease detection, management and treatment for patients with diabetes and other at-risk, large-scale patient populations.
    [Show full text]
  • Curriculum Vitae
    Benjamin R. Lee, M.D. CURRICULUM VITAE Name Benjamin R. Lee, M.D. Present Position Professor and Chief of Urology with tenure University of Arizona College of Medicine Program Director, Urology Residency Present Location Division of Urology Arizona Health Sciences Center 1501 N. Campbell Ave., PO Box 245077 Tucson, AZ 85724-5077 (520) 626-6895 (Phone) (520) 626-4933 (FAX) Email Address [email protected] Education 1986-1990 Bachelor of Arts, Biological Sciences, Magna Cum Laude College of Arts and Sciences Cornell University, Ithaca, New York Senior Honors Thesis: Binding Studies of cell surface Immunoglobulin E- receptor complexes 1990-1994 M.D., Doctor of Medicine The Johns Hopkins School of Medicine Baltimore, Maryland Page 1 of 76 Benjamin R. Lee, M.D. Training / Education / Position General Surgery Internship 1994-95 The Johns Hopkins Hospital General Surgery Resident 1995-96 The Johns Hopkins Hospital Urology Resident 1996-00 The James Buchanan Brady Urological Institute The Johns Hopkins Hospital Assistant Chief Of Service (ACS) 2000-01 The Johns Hopkins Hospital Assistant Professor 2001-04 North Shore - Long Island Jewish Medical Center Albert Einstein College of Medicine Associate Professor 2004-08 North Shore - Long Island Jewish Medical Center Albert Einstein College of Medicine Director, Laparoscopy Section, Long Island Jewish Medical Center Professor (with tenure) 2008-16 Department of Urology Tulane University School of Medicine Director, Fellowship Program in Robotics, Laparoscopy & Endourology Professor 2010-16 Professor of Medicine, Section of Hematology-Oncology Tulane University School of Medicine Professor & Chief (with tenure) 2016-present Division of Urology Department of Surgery University of Arizona College of Medicine Director, GU Cancer & Disease Oriented Strategic Planning Team University of Arizona Cancer Center Program Director, Urology Residency Certification Diplomate, American Board of Urology, #13100, expires 2/28/2023 DaVinci Robotic Training Certificate 2005 Page 2 of 76 Benjamin R.
    [Show full text]
  • The Urology Residency Program of the Icahn School of Medicine at Mount Sinai
    THE UROLOGY RESIDENCY PROGRAM OF THE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Overview The Icahn School of Medicine at Mount Sinai Urology Residency Program is an ACGME-accredited program with a training format consisting of one year of preliminary training in general surgery followed by four years of urology. Its home institution is The Mount Sinai Hospital in New York City. The program is currently approved for a complement of five residents per training year. The program curriculum assures that over the course of training, every resident receives ample experience and didactic grounding in all of the core domains and techniques of urology while acquiring the professional skills and competencies that are characteristic of excellent physicians. Each of the 19 rotations that comprise the curriculum include experience in both in-patient and out-patient treatment settings, with selected rotations offering concentrated experience in areas such as pediatric urology, urodynamics, endourology, female urology, infertility and oncology. An overarching schedule of conferences (led by faculty, fellow residents and guest lecturers), collaborative research projects and support for participation in professional organizations and special programs knit the residents’ clinical experience into the fabric of current urologic scholarship. Our home and affiliated institutions offer an immersive experience in three distinct health care delivery models: the tertiary care academic medical center, the community hospital and the municipal hospital system. Our graduates finish the program with an enviable understanding of the options that are open to them, and well equipped to pursue the urology careers of their choosing. Home and Affiliated Institutions The Mount Sinai Health System consists of seven hospital campuses, each of them a venerable New York institution, located in Manhattan, Brooklyn and Queens.
    [Show full text]